Real-world evidence to guide healthcare policies in oncology

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Real-world evidence to guide healthcare policies in oncology. / Donia, Marco; Hansen, Steen Werner; Svane, Inge Marie.

In: OncoTarget, Vol. 10, No. 44, 2019, p. 4513-4515.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Donia, M, Hansen, SW & Svane, IM 2019, 'Real-world evidence to guide healthcare policies in oncology', OncoTarget, vol. 10, no. 44, pp. 4513-4515. https://doi.org/10.18632/oncotarget.27077

APA

Donia, M., Hansen, S. W., & Svane, I. M. (2019). Real-world evidence to guide healthcare policies in oncology. OncoTarget, 10(44), 4513-4515. https://doi.org/10.18632/oncotarget.27077

Vancouver

Donia M, Hansen SW, Svane IM. Real-world evidence to guide healthcare policies in oncology. OncoTarget. 2019;10(44):4513-4515. https://doi.org/10.18632/oncotarget.27077

Author

Donia, Marco ; Hansen, Steen Werner ; Svane, Inge Marie. / Real-world evidence to guide healthcare policies in oncology. In: OncoTarget. 2019 ; Vol. 10, No. 44. pp. 4513-4515.

Bibtex

@article{9ce15f1edefd43569f14df9655938495,
title = "Real-world evidence to guide healthcare policies in oncology",
abstract = "Randomized controlled clinical trials (RCTs) in oncology enroll patients who meet strict protocol-specified criteria. Many of these criteria overlap across multiple RCTs. A vast proportion of patients with metastatic cancer do not meet such criteria. Hence, patient populations encountered in clinical practice are essentially different from RCT-populations, questioning the representativeness of these trials. A real-world evidence approach, using data from clinical practice, is increasingly employed to complement the information on drug safety and efficacy obtained from traditional clinical trials.",
author = "Marco Donia and Hansen, {Steen Werner} and Svane, {Inge Marie}",
year = "2019",
doi = "10.18632/oncotarget.27077",
language = "English",
volume = "10",
pages = "4513--4515",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "44",

}

RIS

TY - JOUR

T1 - Real-world evidence to guide healthcare policies in oncology

AU - Donia, Marco

AU - Hansen, Steen Werner

AU - Svane, Inge Marie

PY - 2019

Y1 - 2019

N2 - Randomized controlled clinical trials (RCTs) in oncology enroll patients who meet strict protocol-specified criteria. Many of these criteria overlap across multiple RCTs. A vast proportion of patients with metastatic cancer do not meet such criteria. Hence, patient populations encountered in clinical practice are essentially different from RCT-populations, questioning the representativeness of these trials. A real-world evidence approach, using data from clinical practice, is increasingly employed to complement the information on drug safety and efficacy obtained from traditional clinical trials.

AB - Randomized controlled clinical trials (RCTs) in oncology enroll patients who meet strict protocol-specified criteria. Many of these criteria overlap across multiple RCTs. A vast proportion of patients with metastatic cancer do not meet such criteria. Hence, patient populations encountered in clinical practice are essentially different from RCT-populations, questioning the representativeness of these trials. A real-world evidence approach, using data from clinical practice, is increasingly employed to complement the information on drug safety and efficacy obtained from traditional clinical trials.

U2 - 10.18632/oncotarget.27077

DO - 10.18632/oncotarget.27077

M3 - Journal article

C2 - 31360300

VL - 10

SP - 4513

EP - 4515

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 44

ER -

ID: 237517357